Evelyn Mok Lee

Title: Innovations in Glycated Hemoglobin Assays by Evelyn Mok Lee

Introduction

Evelyn Mok Lee is a notable inventor based in Skokie, IL (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of glycated hemoglobin assays. With a total of 2 patents, her work has the potential to enhance diabetes management and patient care.

Latest Patents

Evelyn's latest patents focus on the determination of % glycated hemoglobin (GHb) in whole blood samples. The assay utilizes a straightforward procedure that correlates with the Diabetes Control and Complications Trial (DCCT). Initially, a lysed whole blood sample is incubated with a solid phase coupled with boronic acid or a similar boronate compound through known covalent linkage chemistries. Following this, a labeled antibody to human hemoglobin is introduced, and the resulting signal is directly proportional to the %GHb in the sample. This method offers high precision and is easily automatable, allowing for high throughput. The automation of this assay can also facilitate its consolidation with other testing on a single analyzer. Importantly, this innovative method eliminates the need for two separate measurements: one for GHb and another for total hemoglobin (THb).

Career Highlights

Evelyn Mok Lee is currently associated with Abbott Laboratories Corporation, where she continues to advance her research and innovations in medical diagnostics. Her work is instrumental in improving the accuracy and efficiency of diabetes testing.

Collaborations

Evelyn has collaborated with esteemed colleagues, including David A Westerberg and Haiou H Yao, to further enhance the development of her patented technologies.

Conclusion

Evelyn Mok Lee's contributions to glycated hemoglobin assays represent a significant advancement in diabetes diagnostics. Her innovative approach not only improves testing precision but also streamlines the process, ultimately benefiting patient care.